A Human Sodium-Dependent Vitamin C Transporter 2 Isoform Acts as a Dominant-Negative Inhibitor of Ascorbic Acid Transport
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Vitamin C is transported as ascorbic acid (AA) through the sodium-ascorbate cotransporters (SVCT1 and -2) and as dehydroascorbic acid (DHA) through the facilitative glucose transporters. All cells have glucose transporters and take up DHA that is trapped intracellularly by reduction and accumulated as AA. SVCT2 is widely expressed in cells and tissues at the mRNA level; however, only specialized cells directly transport AA. We undertook a molecular analysis of SVCT2 expression and discovered a transcript encoding a short form of human SVCT2 (hSVCT2-short) in which 345 bp is deleted without a frame shift. The deletion involves domains 5 and 6 and part of domain 4. cDNA encoding this isoform was isolated and expressed in 293T cells, where the protein was detected on the plasma membrane. Transport studies, however, revealed that hSVCT2-short gave rise to a nonfunctional transporter protein. hSVCT2-short arises by alternative splicing and encodes a protein that strongly inhibited the function of SVCT2 and, to a lesser extent, SVCT1 in a dominant-negative manner, probably by protein-protein interaction. The expression of hSVCT2-short varies among cells. PCR analysis of cDNA isolated from melanocytes capable of transporting AA revealed a predominance of the full-length isoform, while HL-60 cells, which express SVCT2 at the mRNA level and were incapable of transporting AA, showed a predominance of the short isoform. These findings suggest a mechanism of AA uptake regulation whereby an alternative SVCT2 gene product inhibits transport through the two known AA transporters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A family of mammalian Na+-dependent L-ascorbic acid transporters
Tsukaguchi, H., Tokui, T., Mackenzie, B., Berger, U. V., Chen, X.-Z., Wang, Y., Brubaker, R. F., & Hediger, M. A. (1999) · Nature · doi:10.1038/19986 · Cited by 882
Criteria and recommendations for vitamin C intake
Levine, M. (1999) · JAMA · doi:10.1001/jama.281.15.1415 · Cited by 559
Sotiriou, S., Gispert, S., Cheng, J., Wang, Y., Chen, A., Hoogstraten-Miller, S., Miller, G. F., Kwon, O., Levine, M., Guttentag, S. H., et al. (2002) · Nature Medicine · doi:10.1038/0502-514 · Cited by 367
Daruwala, R., Song, J., Koh, W. S., Rumsey, S. C., & Levine, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01393-9 · Cited by 272 · cited 3×
“A comparison of the kinetic constants suggests that hSVCT2 has 10-fold higher affinity for AA than hSVCT1 (3, 23).”
BackgroundVitamin C transport systems of mammalian cells
Liang, W.-J., Johnson, D., & Jarvis, S. M. (2001) · Molecular Membrane Biology · doi:10.1080/09687680110033774 · Cited by 255 · cited 3×
“Human cells can take up vitamin C by two mechanisms: through the facilitative GLUTs as DHA or via the Na -dependent cotransporters hSVCT1 and -2 as AA (10).”
BackgroundRajan, D. P., Huang, W., Dutta, B., Devoe, L. D., Leibach, F. H., Ganapathy, V., & Prasad, P. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1272 · Cited by 162 · cited 4×
“The size of the hSVCT2-specific transcript was in agreement with previously published data (18, 29).”
BackgroundResultInfluential
Cited by
SVCT1 and SVCT2: Key proteins for vitamin C uptake
Savini, I., Rossi, A., Pierro, C., Avigliano, L., & Catani, M. V. (2008) · Amino Acids · doi:10.1007/s00726-007-0555-7 · Cited by 358
“Regulation based on protein–protein interaction has been demonstrated for the alternatively spliced form of SCVT2, that can act as a dominant negative isoform (Lutsenko et al., 2004).”
BackgroundInfluentialVitamin C transport and its role in the central nervous system
May, J. M. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-2199-9_6 · Cited by 186
“2006), these results could be explained by proteolysis during sample preparation, by expression of short forms of the transporter (Lutsenko et al. 2004), or by variable glycosylation of the protein.”
BackgroundMethodInfluentialThe sodium-dependent ascorbic acid transporter family SLC23
Bürzle, M., Suzuki, Y., Ackermann, D., Miyazaki, H., Maeda, N., Clémençon, B., Burrier, R., & Hediger, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.002 · Cited by 158
May, J. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01350.x · Cited by 108
“This is based on the generation of an alternatively spliced variant of the protein that acts as a dominant-negative inhibitor of ascorbate transporter function (Lutsenko et al., 2004).”
BackgroundChen, A. A., Marsit, C. J., Christensen, B. C., Houseman, E. A., McClean, M. D., Smith, J. F., Bryan, J. T., Posner, M. R., Nelson, H. H., & Kelsey, K. T. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp076 · Cited by 57
Metadata
- Authors
- Lutsenko, E. A., Carcamo, J. M., & Golde, D. W.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2004-04-01
- Volume
- 24
- Issue
- 8
- Pages
- 3150-3156
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2134523349
- Cited by
- 57
- References
- 6
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Human Sodium-Dependent Vitamin C Transporter 2 Isoform Acts as a Dominant-Negative Inhibitor of Ascorbic Acid Transport. https://app.cochat.ai/papers/10.1128/mcb.24.8.3150-3156.2004
- The paper
- Lutsenko, E. A., Carcamo, J. M., & Golde, D. W. (2004). A Human Sodium-Dependent Vitamin C Transporter 2 Isoform Acts as a Dominant-Negative Inhibitor of Ascorbic Acid Transport. Molecular and Cellular Biology. https://doi.org/10.1128/mcb.24.8.3150-3156.2004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.